JP2025506515A5 - - Google Patents
Info
- Publication number
- JP2025506515A5 JP2025506515A5 JP2024547849A JP2024547849A JP2025506515A5 JP 2025506515 A5 JP2025506515 A5 JP 2025506515A5 JP 2024547849 A JP2024547849 A JP 2024547849A JP 2024547849 A JP2024547849 A JP 2024547849A JP 2025506515 A5 JP2025506515 A5 JP 2025506515A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- receptor
- antigen
- tgfβr
- tim3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310355P | 2022-02-15 | 2022-02-15 | |
| US63/310,355 | 2022-02-15 | ||
| PCT/US2023/062475 WO2023158978A2 (en) | 2022-02-15 | 2023-02-13 | Boosting chimeric antigen receptor cells in the blood |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506515A JP2025506515A (ja) | 2025-03-11 |
| JP2025506515A5 true JP2025506515A5 (https=) | 2026-02-17 |
Family
ID=87578966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547849A Pending JP2025506515A (ja) | 2022-02-15 | 2023-02-13 | 血中のキメラ抗原受容体細胞のブースト |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250177442A1 (https=) |
| EP (1) | EP4479537A4 (https=) |
| JP (1) | JP2025506515A (https=) |
| KR (1) | KR20240151812A (https=) |
| CN (1) | CN118946663A (https=) |
| AU (1) | AU2023220999A1 (https=) |
| CA (1) | CA3249176A1 (https=) |
| CO (1) | CO2024012103A2 (https=) |
| IL (1) | IL314427A (https=) |
| MX (1) | MX2024009987A (https=) |
| WO (1) | WO2023158978A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025176860A1 (en) | 2024-02-23 | 2025-08-28 | Charité - Universitätsmedizin Berlin Körperschaft des öffentlichen Rechts | Dual chimeric antigen receptor construct targeting cea and epcam |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2992551A1 (en) * | 2015-07-21 | 2017-01-26 | Novartis Ag | Methods for improving the efficacy and expansion of immune cells |
| KR20180118175A (ko) * | 2016-03-04 | 2018-10-30 | 노파르티스 아게 | 다중 키메라 항원 수용체 (car) 분자를 발현하는 세포 및 그에 따른 용도 |
| BR112019006781A2 (pt) * | 2016-10-07 | 2019-07-30 | Novartis Ag | receptores de antígeno quiméricos para o tratamento de câncer |
| US11242389B2 (en) * | 2018-09-26 | 2022-02-08 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy |
| US20230203178A1 (en) * | 2020-07-06 | 2023-06-29 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Chimeric antigen receptor car or car construct targeting bcma and cd19 and application thereof |
-
2023
- 2023-02-13 WO PCT/US2023/062475 patent/WO2023158978A2/en not_active Ceased
- 2023-02-13 MX MX2024009987A patent/MX2024009987A/es unknown
- 2023-02-13 AU AU2023220999A patent/AU2023220999A1/en active Pending
- 2023-02-13 KR KR1020247030921A patent/KR20240151812A/ko active Pending
- 2023-02-13 EP EP23756994.2A patent/EP4479537A4/en active Pending
- 2023-02-13 CA CA3249176A patent/CA3249176A1/en active Pending
- 2023-02-13 IL IL314427A patent/IL314427A/en unknown
- 2023-02-13 JP JP2024547849A patent/JP2025506515A/ja active Pending
- 2023-02-13 CN CN202380028526.8A patent/CN118946663A/zh active Pending
- 2023-02-13 US US18/837,734 patent/US20250177442A1/en active Pending
-
2024
- 2024-09-05 CO CONC2024/0012103A patent/CO2024012103A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12570743B2 (en) | BCMA-targeting engineered immune cell and use thereof | |
| US20190023764A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| JP2025183279A (ja) | Ｂｃｍａを標的とする操作された免疫細胞及びその使用 | |
| JP2015527070A5 (https=) | ||
| US11725053B2 (en) | Chimeric antigen receptors comprising a human transferrin epitope sequence | |
| RU2015109631A (ru) | Способ и композиции для клеточной иммунотерапии | |
| JP2021519580A5 (https=) | ||
| RU2018105963A (ru) | Антитело против глипикана-3 и его применение | |
| JP2019513347A5 (https=) | ||
| EP3578570A1 (en) | Multifunctional protein | |
| CN109789164B (zh) | 具有gitr胞内结构域作为共刺激结构域的嵌合抗原受体 | |
| JP2021532742A5 (https=) | ||
| WO2022199125A1 (zh) | 一种自分泌IL-15与anti-PD1融合蛋白的免疫细胞 | |
| JP2024534471A5 (https=) | ||
| HK1255208A1 (zh) | 作为用於嵌合抗原受体(car)疗法的t细胞来源的骨髓浸润淋巴细胞(mil) | |
| TWI797610B (zh) | 人源化cd19抗體及其應用 | |
| CN114555791A (zh) | Il-1超家族时空限制性活性细胞因子铠装的免疫应答细胞 | |
| JP2025513626A (ja) | Ｃｉｉｔａ遺伝子がノックアウトされた操作された免疫細胞及びその用途 | |
| JP2023503840A5 (https=) | ||
| CN117187185A (zh) | 一种工程化免疫细胞及其用途 | |
| JP2025506515A5 (https=) | ||
| Hosseini et al. | Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review | |
| WO2024210072A1 (ja) | キメラタンパク質、核酸、ベクター、ｔ細胞又はｎｋ細胞、医薬組成物、組み合わせ物、組み合わせ医薬、及び標的抗原結合タンパク質 | |
| RU2024105406A (ru) | Клетки, экспрессирующие il-10, для улучшенной иммунотерапии рака |